Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIA: Celivarone for Maintenance of Sinus Rhythm in AF/AFL
NCT00233441Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of celivarone in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Sanofi. Started Dec 2004; status: completed.
02
Drugs
celivarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT00233441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233441.